Linden Advisors’s Aspire Biopharma Holdings, Inc. Warrant ASBPW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $40.5K | Hold |
899,999
| – | – | ﹤0.01% | 346 |
|
|
2025
Q1 | $65.7K | Hold |
899,999
| – | – | ﹤0.01% | 258 |
|
|
2024
Q4 | $36.2K | Hold |
899,999
| – | – | ﹤0.01% | 225 |
|
|
2024
Q3 | $34K | Hold |
899,999
| – | – | ﹤0.01% | 209 |
|
|
2024
Q2 | $32.6K | Hold |
899,999
| – | – | ﹤0.01% | 225 |
|
|
2024
Q1 | $30.5K | Hold |
899,999
| – | – | ﹤0.01% | 251 |
|
|
2023
Q4 | $58.5K | Hold |
899,999
| – | – | ﹤0.01% | 226 |
|
|
2023
Q3 | $44.6K | Hold |
899,999
| – | – | ﹤0.01% | 266 |
|
|
2023
Q2 | $49.5K | Hold |
899,999
| – | – | ﹤0.01% | 266 |
|
|
2023
Q1 | $40.5K | Hold |
899,999
| – | – | ﹤0.01% | 335 |
|
|
2022
Q4 | $36.6K | Hold |
899,999
| – | – | ﹤0.01% | 425 |
|
|
2022
Q3 | $131K | Hold |
899,999
| – | – | ﹤0.01% | 475 |
|
|
2022
Q2 | $144K | Buy |
+899,999
| New | +$144K | ﹤0.01% | 510 |
|